Bussiness

Biosimilar Business News Recap: Mepolizumab Study; New Licensing Deal; Hukyndra…

Bio-Thera Solutions began a phase 1 trial for its mepolizumab biosimilar candidate; Biocon Biologics licenses out 2 biosimilars to Yoshindo; and Alvotech and ST

Read More